Stay updated on SB414 PK, PD, Safety in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.

Latest updates to the SB414 PK, PD, Safety in Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedAn NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe revision identifier in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study content, replacing the study details with an access-denied message. This prevents viewing the trial information and related navigation on the ClinicalTrials.gov record.SummaryDifference17%

- Check56 days agoChange DetectedThe page revision metadata was updated from v3.6.5 to v3.6.6, indicating a new version of the page documentation. This maintains the current content without changing study details.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision label updated to v3.6.5, indicating a newer page build has been deployed. This change does not modify the displayed study information or user-visible content.SummaryDifference0.1%

Stay in the know with updates to SB414 PK, PD, Safety in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.